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Mutations in thegeneencodingParkinareamajorcauseof recessiveParkinson’sdisease.RecentworkhasshownthatParkin translocates from
the cytosol to depolarized mitochondria and induces their autophagic removal (mitophagy). However, the molecular mechanisms
underlying Parkin-mediated mitophagy are poorly understood. Here, we investigated whether Parkin interacts with autophagy-
regulating proteins.We purified Parkin and associated proteins fromHEK293 cells using tandem affinity purification and identified the
Parkin interactors using mass spectrometry. We identified the autophagy-promoting protein Ambra1 (activating molecule in Beclin1-
regulated autophagy) as a Parkin interactor. Ambra1 activates autophagy in the CNS by stimulating the activity of the class III phospha-
tidylinositol 3-kinase (PI3K) complex that is essential for the formation of newphagophores.We foundAmbra1, like Parkin, to bewidely
expressed in adult mouse brain, including midbrain dopaminergic neurons. Endogenous Parkin and Ambra1 coimmunoprecipitated
fromHEK293 cells, SH-SY5Y cells, and adultmouse brain.We foundno evidence for ubiquitinationofAmbra1byParkin. The interaction
of endogenous Parkin and Ambra1 strongly increased during prolonged mitochondrial depolarization. Ambra1 was not required for
Parkin translocation to depolarized mitochondria but was critically important for subsequent mitochondrial clearance. In particular,
Ambra1was recruited to perinuclear clusters of depolarizedmitochondria and activated class III PI3K in their immediate vicinity. These
data identify interaction of Parkin with Ambra1 as a key mechanism for induction of the final clearance step of Parkin-mediated
mitophagy.
Introduction
Parkinson’s disease (PD) is an incurable movement disorder
characterized by the relentless loss of substantia nigra dopami-
nergic neurons (Lees et al., 2009). Mutations in PARK2, the gene
encoding the E3 ubiquitin ligase Parkin, are a major cause of
autosomal recessive PD, probably through a loss-of-function
mechanism (Kitada et al., 1998; Shimura et al., 2000). Parkin-
deficient flies (Greene et al., 2003; Clark et al., 2006; Park et al.,
2006) and mice (Palacino et al., 2004) and fibroblasts from PD
patients with PARK2 mutations (Mortiboys et al., 2008) show
evidence of mitochondrial dysfunction. This is intriguing, be-
cause Parkin is essentially a cytosolic protein (Narendra et al.,
2008). However, recent work has shown that Parkin selectively
and rapidly translocates from the cytosol to depolarized mito-
chondria and subsequently induces their autophagic removal
(mitophagy) (Narendra et al., 2008, 2010a; Geisler et al., 2010;
Matsuda et al., 2010; Vives-Bauza et al., 2010). Thus, Parkin may
protect neurons by triggering the clearance of damaged mito-
chondria that would otherwise be a source of oxidative stress and
apoptosis-inducing factors.
The biogenesis of autophagosomes is tightly regulated by a
complex network of autophagy-regulating proteins (Behrends et
al., 2010; Yang and Klionsky, 2010). The process begins with the
formation of a crescent-shaped, double-membrane precursor
structure (the phagophore), which then expands and closes to
form an autophagosome, capable of fusionwith a lysosome.How
translocated Parkin activates the engulfment of mitochondria
by autophagic membranes is not well understood. Recent
work has shown that translocated Parkin ubiquitinates the
mitochondrial outer membrane protein voltage-dependent
anion channel 1 (VDAC1) (Geisler et al., 2010). Ubiquitinated
VDAC1 may then connect with ambient autophagic mem-
branes via recruitment of the adaptor protein p62/SQSTM1
(Geisler et al., 2010). p62 can bind simultaneously to ubiquitin
and LC3, a protein associated with autophagosomes and ex-
panding phagophores (Pankiv et al., 2007). However, other
studies have found p62 to be dispensable for Parkin-mediated
mitophagy (Narendra et al., 2010b; Okatsu et al., 2010).
Whether Parkin also interacts directly with the autophagic
machinery or only indirectly via VDAC1 ubiquitination and
p62 recruitment is unknown. It is also unclear which factors
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trigger the initiation of new phagophore formation around
depolarized mitochondria after Parkin translocation.
Here, we have used tandem affinity purification (TAP) and
mass-spectrometric analysis to investigate whether Parkin inter-
acts with components of the autophagic machinery. We have
identified the autophagy-promoting protein Ambra1 (activating
molecule in Beclin1-regulated autophagy) as a Parkin interactor.
Ambra1 activates autophagy in the CNS by stimulating the activ-
ity of the class III phosphatidylinositol 3-kinase (PI3K) complex
that is essential for the initiation of phagophore formation (Fimia
et al., 2007). Functional deficiency of Ambra1 in mice leads to
impaired autophagy, excessive apoptosis, accumulation of ubi-
quitinated proteins, and embryonic lethality (Fimia et al., 2007).
We show that the interaction of Parkin with Ambra1 strongly
increases during mitochondrial depolarization. Ambra1 is re-
cruited to perinuclear clusters of depolarized mitochondria and
activates class III PI3K in their immediate vicinity. This mecha-
nism allows for localized induction of the final clearance step of
Parkin-mediated mitophagy.
Materials andMethods
Antibodies. The following primary antibodies were used for immunoflu-
orescence (IF) orWestern blot (WB): mouse anti-Parkin (IF, 1:500;WB,
1:4000; clone PRK8; Millipore), rabbit anti-Ambra1 (WB, 1:5000;
FLJ20294; Strategic Diagnostics) (Di Bartolomeo et al., 2010a), rabbit
anti-Ambra1 (IF, 1:250; Covalab) (Di Bartolomeo et al., 2010a), mouse
anti-FLAG (IF, 1:1000;WB, 1:5000; cloneM2; Sigma), rabbit anti-FLAG
(WB, 1:1000; Sigma), mouse anti--actin (WB, 1:5000; clone AC-15;
Sigma), mouse anti-presenilin-1 (WB, 1:1000; clone PS1-loop; Milli-
pore), mouse anti-calretinin (WB, 1:1000; Swant), mouse anti-MAP2
(IF, 1:500; clone SMI 52; Covance), mouse anti-tyrosine hydroxylase (IF,
1:200; Millipore), mouse anti-GFAP (IF, 1:500; clone G-A-5; Sigma),
mouse anti-2,3-cyclic nucleotide-3-phosphodiesterase (CNPase) (IF,
1:200; Millipore), mouse anti-cytochrome c (IF, 1:200; clone 7H8.2C12;
BD Biosciences), sheep anti-cytochrome c (IF, 1:200; c5723; Sigma),
mouse anti-KDEL (Lys-Asp-Glu-Leu) (IF, 1:100; clone 10C3; Stressgen),
mouse anti-GM130 (IF, 1:200; BD Biosciences), mouse anti-LC3 (IF,
1:50; MBL International), rat anti-LAMP-1 (IF, 1:200; 1D4B; Santa Cruz
Biotechnology), rabbit anti-Tom20 (IF, 1:500; FL-145; Santa Cruz Bio-
technology), mouse anti-HA (WB, 1:1000; Covance), goat anti-c-myc
(IF, 1:200; Bethyl), rabbit anti-DNA polymerase  (IF, 4g/ml; Ab2969;
Abcam), mouse anti-GAPDH (WB, 1:5000; 6C5; HyTest), mouse anti-
cytochrome c oxidase subunit 4 (COX IV) (WB, 1:1000; 20E8; Invitro-
gen), and rabbit anti-Pex14p (IF, 1:100; gift from Dr. M. Fransen, K.U.
Leuven, Leuven, Belgium). Peroxidase-linked secondary antibodies for
WB were from GE Healthcare. Secondary antibodies for IF were donkey
anti-mouse IgG Alexa Fluor-488 and -647, anti-rabbit and anti-sheep
IgG Alexa Fluor-555, anti-rat IgG Alexa Fluor-488, and anti-goat IgG
Alexa Fluor-647 (Invitrogen).
cDNAs and siRNAs. The constructs encoding untagged wild-type Parkin
and HA-tagged wild-type and mutant Parkin were described previously
(Winklhofer et al., 2003; Hampe et al., 2006; VanHumbeeck et al., 2008). A
pcDNA3.1 vector containing the His6–FLAG cDNA for N-terminal tagging
was a gift fromDr.M. Fukata (National Institute for Physiological Sciences,
Aichi, Japan). To generate Parkin with an N-terminal His6–FLAG tag, PCR
from untagged Parkin cDNA was performed using forward primer 5-
CCGTCGACATAGTGTTTGTCAGGTTCAACTCCAGCC-3 and reverse
primer 5-GGTCTAGACTACACGTCGAACCAGTCGTCC-3. The PCR
product was digested with SalI/XbaI and cloned into XhoI/XbaI-digested
His6–FLAG vector, resulting in full-lengthN-terminallyHis6–FLAG-tagged
Parkin. The construct was verified by sequencing andWB. A pCMV6–XL4
vector containing human Ambra1 cDNA with a C-terminal Myc—FLAG
tag and a pCMV6 Entry vector containing untagged humanAmbra1 cDNA
were purchased fromOrigene and verified by sequencing andWB. Ambra1
deletion constructs encoding amino acids 1–532 [N-terminal fragment
(NF)], 533–751 [middle fragment (MF)], and 751–1208 [C-terminal frag-
ment (CF)] with C-terminal Myc–FLAG tags were generated from full-
length Ambra1 by PCR amplification and cloned into the SgfI/MluI
restrictionsitesof thepCMV6Entryvector in-framewith theMyc–FLAGtag
provided by the plasmid. Resulting expression constructs were verified by
sequencing and WB. PCR amplification of these deletion constructs was
performed using the following oligonucleotides: NF forward, GCCGC-
GATCGCCATGAAGGTTGTCCC; NF reverse, CGTACGCGTCTCAG-
TCCGCTCGAGAGGTGG; MF forward, GCCGCGATCGCCATGGGCC-
AAACGCCCAGCTCCAGC; MF reverse, CGTACGCGTCCCTGCCAG-
GACCCTGTTAAC; CF forward, GCCGCGATCGCATGGCAGTGATCG-
GTGATGGACAG; and CF reverse, CGTACGCGTCCTGTTCCGTGG.
FLAG-tagged Parkin deletion constructs encoding amino acids 1–76
[ubiquitin-like domain (UBL)], 77–237 (Linker), and 217–465 [RING1–
IBR–RING2 domain (RIR)] were a gift fromDr. J. Feng (State University
of New York at Buffalo, Buffalo, NY) (Yang et al., 2005). An HA-tagged
ubiquitin plasmid construct was a gift from Dr. K. Winklhofer (Max
Planck Institute for Biochemistry, Martinsried, Germany) (Henn et al.,
2007). A FLAG–IB kinase  (IKK) plasmid construct was a gift from
Dr.C. Scheidereit (MaxDelbru¨ckCenter forMolecularMedicine, Berlin,
Germany) (Tegethoff et al., 2003).Ap40(phox)PX–EGFPplasmidconstruct
was a gift from Dr. J. Jung (University of Southern California, Los Angeles,
CA) (Liang et al., 2006). The target sequences of Ambra1 siRNA 1, Ambra1
siRNA 2, and control siRNA were 5-AGAACTGCAAGATCTACAA-3,
5-GGCCTATGGTACTAACAAA-3, and 5-AATTCTCCGAACGTGT-
CACGT-3, respectively (Qiagen) (Ahn et al., 2004; Fimia et al., 2007).
Cell cultures and transfection.HEK293 cells andHeLa cells were grown
in DMEM (Invitrogen) with 25 mM glucose, supplemented with 10%
fetal bovine serum (Greiner), L-glutamax (4 mM), penicillin (100 U/ml),
streptomycin (100 g/ml), and (only for HEK293 cells) non-essential
amino acids (1%). SH-SY5Y cells were grown inDMEMwith L-glutamax
(4 mM) and 25 mM glucose, supplemented with 15% fetal bovine serum,
gentamycin (200 g/ml), and 1% non-essential amino acids. Midbrain
cultures were prepared from E14 mouse embryos or postnatal day 1
mouse pups of either sex based on a hippocampal culture protocol
(Kaech and Banker, 2006). Procedures were approved by the local ethical
committee. Midbrain cultures were grown in Neurobasal medium (In-
vitrogen) supplemented with B-27 (Invitrogen), glutamine (2mM; Invit-
rogen), and GDNF (10 ng/ml; Alomone Labs) and immunostained after
6 d in vitro. HEK293, HeLa, and SH-SY5Y cells were transiently trans-
fected with 80 ng/cm2 cDNA, unless otherwise indicated. TransIT-293
Reagent (Mirus Bio) was used for cDNA transfections in HEK293 cells
and TransIT-HeLaMONSTER kit (Mirus Bio) for cDNA transfections in
HeLa and SH-SY5Y cells. For cotransfections, we used 60 ng/cm2 of each
cDNA. HEK293, HeLa, and SH-SY5Y cells were transfected with 50 nM
siRNAusing theTransIT-TKOReagent (MirusBio). Transfection efficiency
for siRNAs in these cell lines was 75–90%, as determined in control experi-
ments with siRNAs with a 3 fluorescent tag (Qiagen). For the combined
transfection of cDNA and siRNA in HeLa cells, TransIT-HeLaMONSTER
kit andTransIT-TKOReagentwere used according to the instructions of the
manufacturer. Carbonyl cyanidem-chlorophenylhydrazone (CCCP) (Cal-
biochem),valinomycin(Sigma),orDMSOwereadded1dafter transfection.
TAP and mass spectrometry. Twenty-four hours after transfection,
HEK293 cells were washed with ice-cold PBS, collected with a cell
scraper, and resuspended in buffer A (350mMNaCl, 2.7mMKCl, 8.1mM
Na2PO4, 1.8 mM KH2PO4, and 1% Triton X-100, pH 7.4) containing
protease inhibitor cocktail (Roche). After solubilization for 30 min at
4°C, the sample was cleared by centrifugation for 15 min at 20,000 g.
The supernatant was then incubated with pre-equilibrated anti-Flag M2
affinity gel (Sigma) for 1 h at 4°C. The beads were washed with buffer A,
and bound proteins were eluted with buffer B (50 mM Tris-HCl and 150
mM NaCl, pH 7.4) containing FLAG peptides (0.1 g/l; Sigma). The
eluate was supplemented with imidazole (10 mM) and incubated with
nickel beads (PDC Sepharose CL-4B matrix; Affiland) at 4° for 1 h. The
beads were washed with buffer A supplemented with 10 mM imidazole.
Bound proteins were eluted two consecutive times with buffer A supple-
mentedwith250mM imidazole.To concentrate the eluate, 4 vol ofmethanol
was added, followed by overnight storage at20°C. After centrifugation
at 20,000 g for 10min at 4°C and removal of the supernatant, the pellet
was air dried for 1 h, resuspended in 5 Laemmli’s buffer, and heated at
95°C for 10 min. After SDS-PAGE and staining with Coomassie blue
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(Pierce), stained bands and the corresponding
regions in the control lane were excised, in-gel
digested with trypsin, and analyzed by liquid
chromatography tandem mass spectrometry
using an LTQ Orbitrap XL mass spectrometer
(Thermo Fisher Scientific) as described (Ghes-
quie`re et al., 2009). The Mascot Distiller soft-
ware (version 2.2.1; Matrix Science) was used
to generate Mascot generic files (Ghesquie`re et
al., 2009) to identify peptides and proteins us-
ing the Mascot database search algorithm in
the Swiss-Prot database (release 56) with re-
strictions set to human proteins. Acetylation of
protein N termini, deamidation of asparagine
and glutamine, pyroglutamate formation of
N-terminal glutamine, methionine oxidation
to methionine sulfoxide, and S-propionamide
modification on cysteine were set as variable
modifications. Trypsin was set as enzyme al-
lowing for one missed cleavage. The mass tol-
erance on the precursor ion was set to 10 ppm
and on fragment ions to 0.5 Da. Only peptides
that were ranked first and scored higher than
the corresponding Mascot threshold score for
identity at 99% confidence were withheld. Two
complete runs of TAP-MS were performed.
Only proteins that were not present in the neg-
ative control lane were considered positively
identified.
Coimmunoprecipitation and Western blot.
For coimmunoprecipitation from HEK293
cells, cells were washed with ice-cold PBS, re-
moved with a scraper, and resuspended in lysis
buffer (20 mM Tris-HCl and 1% Triton X-100,
pH 7.4). After solubilization for 30 min at 4°C,
insoluble material was removed by centrifuga-
tion at 20,000  g for 5 min. Protein concen-
trations were determined using the Bio-Rad
Protein assay. The sample was precleared by
incubation with protein A or G Sepharose (GE
Healthcare) for 30 min at 4°C. The beads were
removed by centrifugation and the samples
were incubated for 1 h at 4° with mouse anti-
Parkin (Millipore), rabbit anti-Ambra1 (Stra-
tegic Diagnostics), or control IgG (purified
mouse or rabbit IgG; Millipore). The antigen–
antibody complexes were captured by addition
of protein A or G Sepharose for 1 h at 4°C and
washed three times with buffer A. Proteins
were released from the beads by heating at 95°C
for 10 min in 5 Laemli’s buffer, followed by
SDS-PAGE, blotting onto PVDF membranes,
and incubation with blocking solution, pri-
mary and secondary antibodies. Immunoreac-
tion was visualized with ECL (Pierce) or ECL
Plus (GE Healthcare) and exposure to Amer-
sham Hyperfilm ECL (GE Healthcare). The
density of scanned signals was measured with
UN-SCAN-IT gel 6.1 (Silk Scientific). For co-
immunoprecipitation from brain, brain from
2- to 4-month-oldmicewas homogenizedwith
a glass pestle in 10 vol of 20 mM Tris-HCl, pH
7.4, followed by trituration through a 200 l
pipette tip. Homogenates were centrifuged at
200  g for 5 min, followed by centrifugation
of the supernatant for 5 min at 350  g. After
an additional spin of the supernatant at
20,000 g for 2 min, Triton X-100 was added
to the supernatant to a final concentration of
Figure 1. Parkin binds to Ambra1. A, TAP flow chart. B, Schematic of untagged and TAP-tagged Parkin. RING, RING finger
domain; IBR, in-between-ring domain. C, Enrichment of TAP-tagged Parkin during TAP. Extracts of HEK293 cells transfected with
untagged or TAP-tagged Parkin were subjected to TAP. Extract, Initial cell extract; FT, flow-through; El, eluate. The successive
fractionswere analyzedby SDS-PAGE andWestern blotwith anti-Parkin. The sameamount of total protein (0.2g)was loadedon
the gel for each fraction. D, A total of 4000 cm 2 of HEK293 cell culture was transfected with untagged or TAP-tagged Parkin, and
extractswere subjected to TAP. Final TAP eluateswere analyzed by SDS-PAGE andWestern blotwith anti-Parkin or Coomassie blue
staining. 1, Untagged Parkin; 2, empty lane; 3, TAP-tagged Parkin; asterisk, Parkin band; arrow, Ambra1-containing band, as
determined bymass spectrometry. E, F, Control experiments for the anti-Ambra1 antibody (Strategic Diagnostics) used for WB in
this study. E, HEK293 cells were transiently transfected with empty vector or FLAG-tagged Ambra1 (20 ng/cm 2 cDNA). Protein
extractswere analyzedwith SDS-PAGE andWBwith anti-Ambra1 or anti-FLAG. Anti-Ambra1 recognized endogenousAmbra1 and
transfected Ambra1, whereas anti-FLAG only detected transfected Ambra1. F, HEK293 cells were untransfected (Untransf.) or
transfected with control (Ctrl.) siRNA, Ambra1 siRNA 1, or Ambra1 siRNA 2. At 24 h after transfection, SDS-PAGE and WB were
performedwith the indicated antibodies. The observed knockdown of the endogenous anti-Ambra1 band afterAmbra1 siRNA 1 or
2 transfection confirmed the specificity of this antibody. G, Transfection of TAP-tagged versus untagged Parkin in HEK293 cells
followedbyTAP, SDS-PAGEof the TAPeluates, andWBwith anti-Ambra1or anti--actin.H, I, Extracts fromuntransfectedHEK293
cells (H ) or adult mouse brain (I ) were subjected to immunoprecipitation (IP) with anti-Ambra1 or control IgG, followed byWB of
input and IP fractionswith the indicatedantibodies. Presenilin 1 inHand calretinin in Iare shownasnegative controls. J,K, Extracts
from untransfected HEK293 cells (J ) or mouse brain (K ) were subjected to IP with anti-Parkin or control IgG, followed by WB of
input and IP fractions with the indicated antibodies. L, Parkin deletion constructs used in this study. All deletion constructs had an
N-terminal FLAG tag. M, HEK293 cells were cotransfected with untagged full-length Ambra1 and each of the indicated FLAG-
tagged Parkin deletion constructs. Cell extracts were subjected to IP with anti-Ambra1, followed by WB of input and IP fractions
with the indicated antibodies. L, Linker domain.N, Ambra1 deletion constructs used in this study. All constructs had a C-terminal
Myc–FLAG tag. WD40, WD40 repeat-containing domain. O, Extracts from HEK293 cells cotransfected with untagged Parkin and
each of the indicated FLAG-tagged Ambra1 deletion constructswere subjected to IPwith anti-Parkin, followed byWBof input and
IP fractions with the indicated antibodies.
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1%. After incubation for 30 min at 4°C, the sample was centrifuged at
20,000 g for 5 min. The protein concentration of the supernatant was
determined, followed by preclearing and coimmunoprecipitation as de-
scribed above.
Ubiquitination assay. Ubiquitination was assayed as described (Henn
et al., 2007). One day after transfection, proteins were extracted in dena-
turating lysis buffer (50 mM Tris-HCl, pH 7.4, 5 mM EDTA, 1% SDS, 15
U/ml DNase I, and protease inhibitor cocktail) and boiled for 5 min.
Protein extracts were then diluted 1:10 with non-denaturating lysis buf-
fer (50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 5 mM EDTA, 1% Triton
X-100, and protease inhibitor cocktail), followed by preclearing and im-
munoprecipitation as described above.
Cell fractionation. Cytosolic and mitochondria-enriched cell fractions
were prepared as described (Gegg et al., 2010). In brief, SH-SY5Y cells
were scraped off the plate, washed in PBS, and homogenized with a glass
pestle in isolation medium (250 mM sucrose, 1 mM EDTA, and 10 mM
Tris, pH 7.4). Nuclei were removed by centrifugation (1500  g) for 2
min at 4°C. After centrifugation at 11,800 g for 15min at 4°C, the pellet
(enriched in mitochondria) was separated from the supernatant (con-
taining cytosol) and resuspended in isolation medium.
Immunocytochemistry, confocal microscopy, and image analysis. Cells
grown on poly-D-lysine (Sigma)-coated coverslips were washed with
PBS, fixed in 4% paraformaldehyde in PBS for 30min, washed with PBS,
and blocked and permeabilized for 45min in PBS containing 5% donkey
serum and 0.1%Triton X-100. Cells were incubated for 1 h with primary
antibodies in PBS containing 0.1% Triton X-100 and 2% donkey serum.
After washing, secondary antibodies were applied for 1 h in PBS contain-
ing 0.1% Triton X-100 and 2% donkey serum. Nuclei were stained with
TOTO-3 iodide (1M in the secondary antibody solution; Invitrogen) or
with DAPI in the mounting medium. Cells were mounted onto micro-
scope slides with Vectashield (Labconsult). Confocal images with 1 m
slice thickness were acquired with an Axioskop 2 microscope (LSM510
META; Carl Zeiss) at room temperature equipped with an AxioCamHR
camera (Carl Zeiss), using a 63, NA 1.4 oil Plan-Apochromat objective.
Brightness and contrast were adjusted with NIH ImageJ software. In
translocation, clustering, and mitophagy experiments, random images
were captured and analyzed by an investigator blinded to the experimen-
tal condition. A minimum of 100 cells per condition were analyzed per
experiment.
Statistics. Significance of differences was analyzed with two-tailed Stu-
dent’s t test for comparison between two groups and with one-way
ANOVA and post hoc Holm–Sidak test for comparison between more
than two groups (SigmaStat 3.5; Systat). Values and error bars represent
mean SEM.
Results
Ambra1 is a non-substrate interactor of Parkin
TAP combines two high-affinity binding and two highly specific
elution steps, resulting in the enrichment of the protein of inter-
est and its interacting proteins (Fig. 1A) (Collins andChoudhary,
2008; Wakabayashi et al., 2009). A His6–FLAG TAP tag was
linked to the N terminus of Parkin (Fig. 1B). Similar to untagged
Parkin, TAP-tagged Parkin translocated to depolarized mito-
chondria and induced their removal, indicating that the tag did
not interfere with Parkin-mediatedmitophagy (data not shown).
For purification, TAP-tagged Parkin was expressed in HEK293
cells in basal culture conditions, whereas HEK293 cells trans-
fected with untagged Parkin served as negative control. Expres-
sion levels of TAP-tagged and untagged Parkin were similar (data
not shown). Cell extracts were subjected to TAP in native condi-
tions, followed by concentration and SDS-PAGE of the final TAP
eluates. Figure 1C illustrates the strong enrichment of TAP-
tagged Parkin. Approximately 10% of the TAP-tagged Parkin
present in the initial extract was recovered in the final TAP eluate
(data not shown). After Coomassie blue visualization of bound
proteins, stained bands (Fig. 1D), along with the corresponding
portions of the negative control lane, were excised, in-gel digested
with trypsin, and analyzed by mass spectrometry. We confirmed
a total of eight previously reported Parkin interactors (Table 1).
Among these, histone deacetylase 6 (HDAC6) (Lee et al., 2010)
and - and -tubulin (Lee et al., 2010; Okatsu et al., 2010; Vives-
Bauza et al., 2010) have been implicated previously in Parkin-
mediated mitophagy.
Interestingly, we also identified the 142 kDa autophagy-
activating protein Ambra1 in the TAP eluate (Fig. 1D; Table 1).
This was confirmed by SDS-PAGE and Western blot analysis of
the TAP eluate with an Ambra1-specific antibody (Fig. 1E–G). In
addition, the interaction of Parkin and Ambra1 was validated by
reciprocal coimmunoprecipitation of the endogenous proteins
from HEK293 cells and adult mouse brain (Fig. 1H–K).
To determine which domains of Parkin and Ambra1 interact,
we used various deletion constructs of Parkin (Fig. 1L) and Am-
bra1 (Fig. 1N). Coimmunoprecipitation experiments inHEK293
cells indicated that the interaction of Parkin and Ambra1 was
mediated by the Linker domain of Parkin and the N-terminal
region of Ambra1 (Fig. 1M,O).
We then transfected wild-type Parkin and the PD-linked Parkin
mutantsA82E,K161N,K211N,R256C,andR275WinHEK293cells
to compare the ability of the Parkin variants to coimmunoprecipi-
tate with Ambra1 but found that these mutations did not disrupt
Ambra1 binding (data not shown).
Ambra1 is expressed in both embryonic and adult CNS (Fimia
et al., 2007). We compared the regional distributions of Ambra1
and Parkin in adult mouse brain using Western blotting. Like
Parkin, Ambra1 was expressed throughout the brain, including
midbrain and striatum (Fig. 2A). We then used a specific anti-
Ambra1 antibody (Fig. 2B,C) for immunostaining of endoge-
nous Ambra1 in embryonic and postnatal mesencephalic
cultures. Ambra1 immunostaining was strong in neurons (Fig.
2D), including dopaminergic neurons (Fig. 2E,F ), and was
weak or undetectable in non-neuronal cells, such as astrocytes
and oligodendrocytes (Fig. 2G,H ). Similar to Parkin, Ambra1
was predominantly localized in the cytosol (Fig. 2 I) and
Table 1. Mass spectrometric identification of Ambra1 and 8 previously reported Parkin interactors
Swiss-Prot accession number Gene symbol Protein name Number of unique peptides identified Sequence coverage (%) Reference
Q9C0C7 AMBRA1 Ambra1 6 7
P68363 TUBA1B Tubulin-1B chain 9 32 Ren et al., 2003
P07437 TUBB Tubulin chain 15 51 Ren et al., 2003
P63261 ACTG1 Actin, cytoplasmic 2 12 41 Kim and Son, 2010
P38646 HSPA9 Stress-70 protein, mitochondrial (GRP-75) 17 35 Davison et al., 2009
P10809 HSPD1 60 kDa heat shock protein, mitochondrial (HSP-60) 8 21 Davison et al., 2009
P78371 CCT2 T-complex protein 1 subunit (TCP-1-) 10 31 Imai et al., 2003
P17987 TCP1 T-complex protein 1 subunit (TCP-1-) 6 12 Imai et al., 2003
Q9UBN7 HDAC6 Histone deacetylase 6 1 1 Jiang et al., 2008
The references refer to the publications that first described the biochemical interaction of Parkin with the respective proteins.
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showed little colocalization with cellular organelles in basal
conditions (Fig. 2 J–N ).
Because Parkin is an E3 ubiquitin ligase (Shimura et al., 2000),
we asked whether Ambra1 might be a substrate for Parkin-
mediated ubiquitination. We performed a ubiquitination assay
(Fig. 3) (Henn et al., 2007) inHeLa cells, a cell linewith little or no
endogenous Parkin expression (Denison et al., 2003; Pawlyk et
al., 2003). HeLa cells were transfected with various combinations
of Parkin, Ambra1, and HA-tagged ubiquitin. Proteins were ex-
tracted in denaturing conditions to dissociate Ambra1 from its
binding partners. The extracts were then diluted in non-
denaturing buffer to allow immunoprecipitation of Ambra1 with
Figure 2. Anatomical, cellular, and subcellular distribution of Ambra1. A, Extracts from 2-month-old mouse brain regions were analyzed using SDS-PAGE and Western blot with the indicated
antibodies. Mes., Mesencephalon; Cbl., cerebellum; Thal., thalamus; Striat., striatum; Olf., olfactory bulb. B, C, Control experiments for the anti-Ambra1 antibody (Covalab) used for immunocyto-
chemistry in this study.B, HEK293 cells were transiently transfectedwith FLAG-tagged Ambra1 and double labeledwith anti-Ambra1 and anti-FLAG. Note that endogenous Ambra1 in HEK293 cells
is below the immunocytochemical detection threshold of this anti-Ambra1 antibody. C, SH-SY5Y cells were untransfected (Untransf.) or transfected with control (Ctrl.) siRNA, Ambra1 siRNA 1, or
Ambra1 siRNA 2. At 24 h after transfection, cells were immunostained with anti-Ambra1. Note that endogenous Ambra1 is detectable in this neural cell line. The observed suppression of the
endogenous anti-Ambra1 signal after Ambra1 siRNA 1 or 2 transfection confirmed the specificity of this antibody. D–H, Embryonic (D, E, G, H ) or postnatal (F ) mesencephalic cultures on day 6 in
vitrowere double labeledwith anti-Ambra1 and anti-MAP2, a neuronalmarker (D), anti-tyrosine hydroxylase (TH), amarker of dopaminergic neurons (E, F ), anti-GFAP, an astrocytemarker (G), or
anti-CNPase, an oligodendrocytemarker (H ). Arrowhead inD indicates a non-neuronal (MAP2-negative) cell. Microscope settings inG andH are identical to those used inD–F, so that the intensity
of Ambra1 staining in glial cells can be comparedwith that in neurons. I, Embryonic mesencephalic cultures were double labeled with anti-Ambra1 and anti-Parkin, revealing partial colocalization
of the endogenous proteins in the neuronal cytosol. J–N, Embryonic mesencephalic cultures were double labeled with anti-Ambra1 and either anti-cytochrome c, a mitochondrial marker (J ),
anti-KDEL, an ERmarker (K ), anti-GM130, a Golgimarker (L), anti-LC3, an autophagosomemarker (M ), or anti-LAMP-1, a lysosomalmarker (N ). Cell nuclei were stainedwith DAPI or TOTO-3. Scale
bars, 10m.
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anti-Ambra1 antibody. Finally, Western blot analysis with anti-HA
was performed on the immunoprecipitates to detect ubiquiti-
nated Ambra1 (Fig. 3A). As a positive control for Parkin-
mediated ubiquitination, we transfected the Parkin substrate
nuclear factorB essentialmodulator (IKK) (Henn et al., 2007).
As reported, cotransfection of Parkin clearly increased the
amount of ubiquitinated IKK (Fig. 3B) (Henn et al., 2007). In
contrast, ubiquitination of Ambra1was not increased in the pres-
ence of Parkin (Fig. 3A). The detection of small amounts of ubi-
quitinated Ambra1 in HeLa cells lacking Parkin suggested that
Ambra1 can be ubiquitinated by other E3 ligases than Parkin.We
performed similar ubiquitination experiments in HEK293 cells
but again did not find an increase in Ambra1 ubiquitination dur-
ing cotransfection of Parkin (Fig. 3C). Together, these findings
suggest that Ambra1 is not a target for Parkin-mediated ubiquiti-
nation but do not exclude the possibility that Parkinmay ubiqui-
tinate Ambra1 in other cell types or in different experimental
conditions.
Mitochondrial depolarization promotes the interaction of
Parkin with Ambra1
Parkin mediates mitophagy after prolonged dissipation of the
mitochondrial membrane potential with protonophores, such as
CCCP (Narendra et al., 2008, 2010a; Geisler et al., 2010;Matsuda
et al., 2010; Vives-Bauza et al., 2010). We wondered whether
mitochondrial depolarizationmight affect the interaction of Par-
kin with Ambra1. Indeed, exposure of untransfected HEK293
cells (Fig. 4A) or untransfected dopaminergic neural SH-SY5Y
cells (Fig. 4B) to CCCP for 12 h strongly increased the binding of
endogenous Parkin to Ambra1. In untransfected HEK293 cells,
the amount of Parkin coimmunoprecipitated with anti-Ambra1
after 12 h treatment with CCCP (10 M), normalized to the
amount coimmunoprecipitated after 12 h treatment with
DMSO, was 6.9  1.8 (p  0.05; n  3). In untransfected SH-
SY5Y cells, the amount of Parkin coimmunoprecipitated with
anti-Ambra1 after 12 h of CCCP (25 M) treatment, normalized
to the DMSO condition, was 8.4 1.4 (p 0.01; n 3). There
was no clear increase in binding of the endogenous proteins after
only 3 h exposure to CCCP (data not shown).
Next, we performed coimmunoprecipitation after cellular
fractionation (Fig. 4C) in untransfected SH-SY5Y cells to deter-
mine whether the increased interaction of endogenous Parkin
and Ambra1 during prolongedmitochondrial depolarization oc-
curred in the cytosol or in the mitochondrial fraction. In basal
conditions, binding of endogenous Parkin and Ambra1 was de-
tected in both the cytosolic andmitochondria-enriched fractions
(Fig. 4D). However, increased binding after prolonged exposure
toCCCPwas only observed in themitochondrial fraction andnot
in the cytosolic fraction (Fig. 4D).
Figure 3. Parkin does not ubiquitinate Ambra1. HeLa cells (A, B) or HEK293 cells (C) were
transfected with various combinations of HA-tagged ubiquitin (HA-Ub), FLAG-tagged IKK,
Parkin, and Ambra1, as indicated. At 24 h after transfection, extracts were made in denaturing
conditions. After dilution in non-denaturing buffer, immunoprecipitation (IP) was performed
with anti-FLAG, anti-Ambra1, or control IgG. The IP and input samples were resolved by SDS-
PAGE andWestern blot with the antibodies indicated to the right of the blots. In B, a short and
a more prolonged film exposure of the same anti-HA blot is shown.
Figure 4. Mitochondrial depolarization promotes the interaction of endogenous Parkin and
Ambra1. A, B, Untransfected HEK293 cells (A) or untransfected SH-SY5Y cells (B) were treated
with CCCP (10M in A; 25M in B) or DMSO for 12 h, followed by immunoprecipitation (IP) of
the cell extracts with anti-Ambra1 or control IgG. The input and IP samples were resolved by
SDS-PAGE andWestern blot with the indicated antibodies. C, Extracts from SH-SY5Y cells were
fractionated into a cytosolic (C) and a mitochondria-enriched (M) fraction. After loading the
same total amount of protein on the gel for each fraction, SDS-PAGE and immunoblottingwere
performed for the mitochondrial marker Tom20 and the cytosolic marker GAPDH. D, Untrans-
fected SH-SY5Y cells were treated with DMSO or CCCP (25M) for 16 h. Next, cell extracts were
fractionated into cytosolic andmitochondrial fractions, as in C. Immunoprecipitationwith anti-
Ambra1 was then performed on the same total amount of protein for the DMSO- and CCCP-
treated fractions, followed by WB of the immunoprecipitates with anti-Parkin.
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Parkin translocation to depolarized mitochondria is not
Ambra1 dependent
The known role of Ambra1 as an activator of autophagy and the
increase in Parkin–Ambra1 binding during mitochondrial depo-
larization prompted us to test for a possible role of Ambra1 in
Parkin-mediated mitophagy. Parkin-mediated mitophagy oc-
curs in two sequential steps: Parkin first
translocates to depolarized mitochon-
dria and subsequently activates their au-
tophagic elimination (Narendra et al.,
2008, 2010a; Geisler et al., 2010; Matsuda
et al., 2010; Vives-Bauza et al., 2010). We
first determined whether Ambra1 was in-
volved in Parkin translocation. HeLa cells
were transfected with Parkin and treated
with 10 M CCCP or DMSO for 3 h. As
reported previously, CCCP induced a
striking translocation of Parkin from the
cytosol tomitochondria (Fig. 5A,B). Sim-
ilarly, 3 h exposure to 1M valinomycin, a
K ionophore that rapidly dissipates the
mitochondrialmembranepotential (Sharpe
et al., 1995), redistributed Parkin from the
cytosol to the mitochondria (Fig. 5A,B).
Ambra1 did not translocate to depolar-
ized mitochondria to the same extent as
Parkin after 3 h of CCCP exposure, al-
though there was some colocalization of
Ambra1 with mitochondria (Fig. 5C).
We then asked whether CCCP had any
effect on the distribution of endogenous
Parkin in neural cells. Immunocytochem-
ical staining of endogenous Parkin in SH-
SY5Y cells was weak but detectable (Fig.
5D). After exposure to CCCP (25 M) for
3 h, 20.6 1.9% of SH-SY5Y cells showed
clusters of Parkin immunoreactivity that
colocalizedwithmitochondria, compared
with only 5.5 2.1% of cells after DMSO
treatment (p 0.01; n 3) (Fig. 5D).
Next, we used RNA interference to re-
duce Ambra1 expression to 20–30% of
control levels (Fig. 5E,F). However, Am-
bra1 downregulation had no effect on
CCCP-induced Parkin translocation in
Parkin-transfected HeLa cells (Fig. 5G,H)
or in SH-SY5Y cells (Fig. 5 I, J ), indicat-
ing that Ambra1 is not required for this
process.
Ambra1 contributes to
Parkin-mediated mitophagy
Next, we investigated whether Ambra1
was involved in the clearance of mito-
chondria after Parkin translocation. As
reported previously, 24 h exposure of
HeLa cells to 10 M CCCP induced the
removal of mitochondria in a Parkin-
dependent manner (Fig. 6A–F) (Naren-
dra et al., 2008, 2010a; Geisler et al., 2010;
Matsuda et al., 2010; Vives-Bauza et al.,
2010). CCCP-induced, Parkin-dependent
mitochondrial clearance was observed us-
ingmarkers of various mitochondrial compartments: Tom20, an
outer membrane protein (Fig. 6A,B); cytochrome c, an inter-
membrane space protein (Fig. 6C,D); and DNA polymerase , a
matrix protein (Fig. 6E,F). As reported previously (Narendra et
al., 2008), CCCP-induced mitochondrial clearance in Parkin-
transfected HeLa cells was inhibited by the lysosomal inhibitor
Figure 5. Ambra1 is not required for Parkin translocation to depolarized mitochondria. A, B, At 24 h after transfection with
Parkin, HeLa cellswere treatedwithDMSO, CCCP (10M), or valinomycin (1M) for 3 h and immunostained for Parkin and Tom20,
a mitochondrial marker. B, Quantification of the percentage of Parkin-expressing cells in which Parkin strongly colocalized with
mitochondria (n  6 for DMSO; n  3 for CCCP and for valinomycin). *p  0.001 compared with DMSO. C, At 24 h after
cotransfectionwith Parkin andAmbra1, HeLa cellswere treatedwithDMSOor CCCP (10M) for 3 h and immunostained for Parkin,
Ambra1, and Tom20. D, Untransfected SH-SY5Y cells were treated with DMSO or CCCP (25M) for 3 h and immunostained for
Parkin and Tom20. Arrowheads inD indicate clusters of Parkin immunoreactivity that colocalizewithmitochondria. E, F, HeLa cells
were untransfected (No transf.) or transfected with control siRNA, Ambra1 siRNA 1, or Ambra1 siRNA 2. At 24 h after transfection,
SDS-PAGE andWestern blotwere performedwith the indicated antibodies. F, The Ambra1 protein level after siRNA treatmentwas
quantified and normalized to the level after control siRNA transfection (n 4). *p 0.001 compared with control siRNA. G, H,
HeLa cells were cotransfected with Parkin and the indicated siRNA. After 24 h, cells were treated for 3 h with CCCP (10M) and
immunostained for Parkin and Tom20.H, Quantification of the percentage of Parkin-expressingHeLa cells inwhich Parkin strongly
colocalizedwithmitochondria (n 3). I, J, SH-SY5Y cellswere transfectedwith the indicated siRNAs. After 24 h, cellswere treated
for 3 h with CCCP (25 M) and immunostained for endogenous Parkin and Tom20. Arrowheads in I indicate clusters of Parkin
immunoreactivity that colocalize with mitochondria. J, Quantification of the percentage of SH-SY5Y cells with Parkin clusters
colocalizing with mitochondria (n 3). Scale bars, 10m.
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bafilomycin A1 (100 nM) and the PI3K in-
hibitor 3-methyladenine (10 mM), con-
firming its autophagic nature (Fig. 6G).
CCCP-induced elimination of mitochon-
dria was selective, because peroxisomes
were not removed (Fig. 6H) (Narendra et
al., 2008). Exposure to valinomycin (1 M)
for 24 h also triggered Parkin-dependent
mitochondrial clearance, similar to CCCP
(Fig. 6A,B).
We wondered whether mitochondrial
depolarization also induced mitochon-
drial clearance in untransfected neural
cells that endogenously express Parkin.
Indeed, exposure to CCCP for 24 h clearly
increased the percentage of SH-SY5Y cells
devoid of mitochondrial staining (Fig.
6 I). The percentage of SH-SY5Y cells
without detectable Tom20 immunoreac-
tivity was 1.3  1.3% after 24 h DMSO
treatment versus 8.4  1.4% after 24 h
treatment with 25 M CCCP (p  0.05;
n  3). Finally, we quantified mitochon-
drial mass in untransfected SH-SY5Y cells
using Western blot for the integral inner
mitochondrial membrane protein cyto-
chrome c oxidase subunit 4 (COX IV)
(Fig. 6 J,K). Treatment with CCCP for
24 h substantially reduced the amount of
COX IV (Fig. 6 J,K) (Lee et al., 2010), and
this decrease was inhibited by bafilomycin
A1 (Fig. 6 J,K).
Next, we used siRNA-mediated down-
regulation of Ambra1 to examine its role
in Parkin-mediated mitophagy. Inter-
estingly, Ambra1 knockdown significantly
suppressed CCCP-induced mitochondrial
clearance in both Parkin-transfected HeLa
cells (Fig. 7A,B) and untransfected SH-
SY5Y cells (Fig. 7C,D), indicating that this
process was dependent on Ambra1.
We then asked whether CCCP-induced
mitophagy might be enhanced by overex-
pression of Ambra1. Ambra1 overexpres-
sion in HeLa cells lacking Parkin did not
result in mitochondrial clearance after 24 h
exposure to CCCP (Fig. 7E,G). However,
coexpression of Ambra1 and Parkin re-
sulted in enhanced CCCP-induced mi-
tophagy compared with overexpression of
Parkin alone (Fig. 7F,G). Thus, Ambra1
overexpression promoted the elimination
of depolarizedmitochondria but only in the
presence of Parkin.
Ambra1 locally activates class III PI3K
around depolarized mitochondria
We then investigated the mechanism
by which Ambra1 contributes to Parkin-
mediated mitophagy. Ambra1 activates
autophagy by stimulating the activity of
the class III PI3K that is crucial for the
initiation of phagophore formation (Fimia
Figure 6. Mitochondrial depolarization induces Parkin-dependentmitophagy.A,B, At 24 h after transfectionwith Parkin, HeLa cells
were treated with DMSO, CCCP (10M), or valinomycin (1M) for 24 h and immunostained for Parkin and Tom20. B, Percentage of
Parkin-positiveandParkin-negativecellswithoutdetectableTom20immunoreactivityafter24htreatmentwithCCCPorDMSO(n11for
DMSO;n8forCCCP;n3forvalinomycin). #p0.001comparedwithCCCP-treatedParkin-negativecells.*p0.001comparedwith
DMSO-treatedParkin-positive cells. §p0.001 comparedwith valinomycin-treatedParkin-negative cells.C,D, At 24hafter transfection
withParkin, HeLa cellswere treatedwithDMSOor CCCP (10M) for 24hand immunostained for Parkin and cytochrome c.D, Percentage
of Parkin-positive and Parkin-negative cells without detectable cytochrome c immunoreactivity after 24 h treatmentwith CCCP or DMSO
(n3). *p0.001 comparedwith CCCP-treatedParkin-negative cells. #p0.001 comparedwithDMSO-treatedParkin-positive cells.
E,F, At24hafter transfectionwithParkin,HeLa cellswere treatedwithDMSOorCCCP (10M) for24hand immunostained forParkinand
DNApolymerase(POLG).F,PercentageofParkin-positiveandParkin-negativecellswithoutdetectablePOLGimmunoreactivityafter24h
treatment with CCCP or DMSO (n 3). *p 0.001 compared with CCCP-treated Parkin-negative cells. #p 0.001 compared with
DMSO-treatedParkin-positivecells.Arrows inA,C, andE indicateParkin-positivecells,andarrowheads indicateParkin-negativecells.G,At
24hafter transfectionwithParkin, HeLa cellswere treated for 24hwith CCCP (10M) alone,with CCCP (10M) andbafilomycinA1 (100
nM), or with CCCP (10M) and 3-methyladenine (3MA; 10 mM) and immunostained for Parkin and Tom20. The percentage of Parkin-
positive and Parkin-negative cells without detectable Tom20 immunoreactivity was quantified (n 3). *p 0.001 compared with
Parkin-positive cells treatedwith CCCPalone.H, At 24hafter transfectionwithParkin, HeLa cellswere treatedwith CCCP (10M) for 24h
andimmunostainedforParkinandPex14p,aperoxisomalmarker. I,UntransfectedSH-SY5YcellsweretreatedwithDMSOorCCCP(25M)
for24handimmunostainedforTom20.J,K,UntransfectedSH-SY5Ycellsweretreatedfor24hwithDMSO,withCCCP(25M),orwithCCCP
(25M) andbafilomycinA1 (Bafilom.; 100nM). Cell extractswere analyzedby SDS-PAGE andWestern blotwith the indicated antibodies.
K, Theamountof COX IVwasquantifiedandnormalized to theamountof COX IV in theDMSOcondition (n7 forDMSOandCCCP;n4
for CCCPbafilomycinA1). *p0.005 comparedwithDMSO. #p0.001 comparedwith CCCPbafilomycinA1. Scale bars, 10m.
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et al., 2007). As shown above (Fig. 4A,B), exposure to CCCP for
12 h strongly increased the interaction of Parkin with Ambra1.
We therefore hypothesized that recruitment of Ambra1 might
enable translocated Parkin to locally activate class III PI3K
around depolarized mitochondria.
To test this hypothesis, we used the p40(phox)PX–EGFP fu-
sion protein. Because the PX domain of p40(phox) specifically
binds to phosphatidylinositol 3-phosphate (PtdIns-3-P), the re-
action product of class III PI3K, the p40(phox)PX–EGFP fusion
protein can be used as a probe formeasuring the subcellular levels
and distribution of PtdIns-3-P (Kanai et al., 2001; Liang et al.,
2006; Fimia et al., 2007). Hotspots of p40(phox)PX–EGFP disap-
peared in HeLa cells after treatment for 1 h with 75 nM of the
specific PI3K inhibitor wortmannin (Fig.
8A), as reported previously (Kanai et al.,
2001). We then cotransfected HeLa cells
with p40(phox)PX–EGFP and Parkin.
After 16 h exposure to 10 M CCCP,
mitochondrial staining had already dis-
appeared in 16.6  4.13% of Parkin-
expressing cells (n  6). In most of the
Parkin-expressing cells that still contained
mitochondria after 16 h of CCCP treat-
ment, the mitochondria were concen-
trated in juxtanuclear clusters that have
recently been called “mito-aggresomes”
(Fig. 8B,D) (Geisler et al., 2010; Lee et al.,
2010; Okatsu et al., 2010; Vives-Bauza et
al., 2010). In contrast, mitochondria re-
mained distributed as a network through-
out the cytosol in cells lacking Parkin.
Remarkably, the perinuclear mitochon-
drial clusters in Parkin-expressing cells
were closely surrounded by and intermin-
gled with p40(phox)PX–EGFP hotspots
(Fig. 8B,D). A similar phenomenon was
observed in SH-SY5Y cells transfected with
p40(phox)PX–EGFP and treated with
CCCPfor16h(Fig. 8C).Parkin transfection
or 16 h of CCCP treatment did not increase
the total number of p40(phox)PX–EGFP
hotspots per cell (data not shown). Interest-
ingly, Parkin-transfected HeLa cells after
16 h of CCCP treatment showed a striking
redistribution of Ambra1 to the jux-
tanuclear mito-aggresomes (Fig. 9A). In
contrast, Ambra1 did not colocalize with
mitochondria inParkin-deficientHeLacells
after 16 h of CCCP treatment (Fig. 9A). Co-
localization of Ambra1 with mitochondria
in Parkin-expressing HeLa cells was clearly
more prominent after 16 h (Fig. 9A) than
after 3 h (Fig. 5C) of CCCP treatment. En-
dogenousAmbra1 in SH-SY5Y cells also re-
distributed to themitochondria after 16hof
CCCP (Fig. 9B).
Finally, we tested whether recruited
Ambra1 was responsible for the local ac-
tivation of class III PI3K around the mi-
tochondrial clusters. Downregulation of
Ambra1 levels with RNAi did not interfere
withParkin-dependentmitochondrial clus-
tering after 16 h of CCCP treatment but
caused a significant reduction of PtdIns-3-P hotspots aroundmito-
aggresomes (Fig. 10A,B). Together, these data showed that Parkin-
dependent recruitment of Ambra1 led to local activation of class III
PI3K around depolarizedmitochondria.
Discussion
Loss of function of the E3 ubiquitin ligase Parkin is one of the
most common known causes of PD (Lees et al., 2009). Recent
work has shown that Parkin surveys mitochondrial quality by
promoting autophagic removal of depolarized mitochondria
(Narendra et al., 2008, 2010a; Geisler et al., 2010; Lee et al.,
2010; Matsuda et al., 2010; Okatsu et al., 2010; Vives-Bauza et
al., 2010). Ambra1 was recently identified as an activator of the
Figure7. Ambra1 contributes toParkin-mediatedmitophagy.A,B, HeLa cellswere cotransfectedwithParkin and the indicated
siRNAs, treated for 24 h with CCCP (10 M) and stained for Parkin and Tom20. Arrows in A indicate Parkin-positive cells, and
arrowheads indicate Parkin-negative cells. B, Quantification of the effect of siRNA-mediated Ambra1 downregulation on CCCP-
induced mitophagy in Parkin-positive cells (n 6–9). *p 0.001 compared with control siRNA condition after CCCP. C, D,
SH-SY5Y cells were transfected with the indicated siRNAs, treated for 24 hwith CCCP (25M), and stained for Tom20. Microscope
settings in C are identical for the different siRNA conditions. Arrow in C indicates a cell with no detectable mitochondrial staining.
D, Quantification of the effect of siRNA-mediated Ambra1 downregulation on CCCP-induced mitochondrial clearance in SH-SY5Y
cells (n 3). *p 0.05 comparedwith control siRNA condition after CCCP. E, At 24 h after transfection with Ambra1 alone, HeLa
cells were treated with DMSO or CCCP (10M) for 24 h and then immunostained for Ambra1 and Tom20. Arrows in E indicate
Ambra1-overexpressing cells. F, At 24 h after cotransfection with Myc-tagged Ambra1 and Parkin, HeLa cells were treated with
DMSO or CCCP (10M) for 24 h and immunostained for Myc, Parkin, and Tom20. Arrows in F indicate cells overexpressing both
Ambra1 and Parkin, and arrowheads indicate cells overexpressing only Parkin. G, HeLa cells were transfected with various combi-
nations ofMyc-taggedAmbra1, Parkin, and empty vector (EV), as indicated. At 24h after transfection, cellswere treatedwith CCCP
(10M) for 24 h. After immunostaining for Myc, Parkin, and Tom20, the percentage of transfected cells devoid of mitochondrial
staining was quantified (n 3–5). *p 0.001 compared with cells transfected with EV alone. #p 0.001 compared with cells
transfected with Parkin and EV. Scale bars, 10m.
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initial steps of phagophore formation in the nervous system
(Fimia et al., 2007). Functional deficiency of Ambra1 leads to
impaired autophagy, accumulation of ubiquitinated proteins,
and excessive apoptosis (Fimia et al., 2007). Here, we demon-
strate a Parkin–Ambra1 interaction, which strongly increases
during mitochondrial depolarization and is crucial for subse-
quent mitophagy.
Parkin-mediated mitophagy involves a chronological se-
quence of events that are only beginning to be understood in
molecular terms. The first step, translocation of Parkin from the
cytosol to depolarized mitochondria, is dependent on PTEN (for
phosphatase and tensin homolog)-induced putative kinase 1
(PINK1), a mitochondrial protein genetically linked to PD (Gei-
sler et al., 2010; Matsuda et al., 2010; Narendra et al., 2010a;
Vives-Bauza et al., 2010). Translocated Parkin then ubiquitinates
outer mitochondrial membrane proteins, such as VDAC1 and
mitofusins 1 and 2 (Ding et al., 2010; Gegg et al., 2010; Geisler et
al., 2010; Lee et al., 2010; Okatsu et al., 2010; Ziviani et al., 2010).
Ubiquitination ofmitochondrial proteins induces recruitment of
p62 (Ding et al., 2010; Geisler et al., 2010; Okatsu et al., 2010),
which simultaneously binds to ubiquitin and LC3, a protein pres-
ent on growing phagophores (Pankiv et al., 2007). Parkin-
mediated mitochondrial ubiquitination also recruits HDAC6
(Lee et al., 2010), which interacts with both ubiquitin and
microtubule-associated dynein motors (Kawaguchi et al., 2003).
During this process, defective mitochondria are trafficked along
microtubules into perinuclear clusters (mito-aggresomes) (Lee et
al., 2010;Okatsu et al., 2010; Vives-Bauza et al., 2010). Finally, the
clustered mitochondria are engulfed by autophagosomes.
We show that Ambra1 is not required for Parkin transloca-
tion or Parkin-mediated perinuclear clustering of depolarized
mitochondria but is a key player in the final clearance of the
mitochondria. More specifically, Ambra1 accumulates around
juxtanuclear clusters of depolarized mitochondria and acti-
vates class III PI3K in their immediate vicinity. Production of
PtdIns-3-P by class III PI3K is a powerful trigger for the for-
mation of new phagophores (Simonsen and Tooze, 2009).
This mechanism thus allows for local stimulation of new
phagophore formation around depolarized mitochondria but
spares the rest of the cell from autophagic degradation. Am-
bra1 recruitment to mito-aggresomes may therefore contrib-
ute to the spatially restricted, selective nature of mitophagy.
Importantly, this activating role of Ambra1 in mitophagy is
strictly dependent on Parkin: in the absence of Parkin, no
Figure 8. Activation of class III PI3K around clusters of depolarized mitochondria. A, At 24 h after transfection with p40(phox)PX–EGFP, HeLa cells were treated for 1 h with 75 nM of the PI3K
inhibitor wortmannin or DMSO. B, HeLa cells were cotransfected with p40(phox)PX–EGFP and Parkin. At 24 h after transfection, cells were treated with DMSO or CCCP (10 M) for 16 h and
immunostained for Parkin and Tom20. The bottom row is a magnification of the boxed area in the row above. C, SH-SY5Y cells were transfected with p40(phox)PX–EGFP. After 24 h, the cells were
treatedwithDMSOor CCCP (25M) for 16hand immunostained for Tom20.D, Quantification of the experiment illustrated inB. Thenumber ofHeLa cellswith perinuclearmitochondrial clusterswas
quantified as a percentage of the total number ofmitochondria-containing cells (black bars; n 3). Also, the number of cells with perinuclearmitochondrial clusters in contact with p40(phox)PX–
EGFP hotspotswas quantified as a percentage of the total number ofmitochondria-containing cells (white bars; n 3). *p 0.001 comparedwith DMSO-treated Parkin-positive cells. #p 0.001
compared with CCCP-treated Parkin-negative cells. Scale bars, 10m.
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CCCP-induced mitophagy occurs, even after overexpression
of Ambra1.
The Parkin–Ambra1 interaction provides a mechanistic link
between Parkin and the autophagy machinery. In a previously
reported molecular connection between Parkin and autophagy,
Parkin-catalyzed ubiquitination of VDAC1 led to p62-mediated
recruitment of LC3 (Geisler et al., 2010). These two molecular
models have different functional implications but are not mutu-
ally exclusive. Because LC3 only associates with phagophores af-
ter they have already started to form (Tooze and Yoshimori,
2010), the VDAC1/p62/LC3 connection can only recruit preex-
isting phagophores but cannot induce the formation of new
phagophores. In contrast, Ambra1 stimulates new phagophore
formation (Fimia et al., 2007). Thus, the two mechanisms could
have complementary effects: Ambra1 induces the perimitochon-
drial formation of new phagophores, which, after incorporation
of LC3, may be tethered to ubiquitinated mitochondria via p62.
According to this scenario, Ambra1 should enhance the dynam-
ics and efficiency of Parkin-mediated mitophagy. Interestingly,
Ambra1 is only found in vertebrates and has no known orthologs
in lower eukaryotes (Di Bartolomeo et al., 2010b). Ambra1 may
have evolved to make removal of damaged mitochondria more
efficient in the long-lived neurons of vertebrates.
We found that Parkin also interacted with Ambra1 in basal
culture conditions (i.e., in the absence of mitochondrial uncou-
plers) and in adultmouse brain. Our cellular fractionation exper-
iments suggest that this basal interaction occurs both in the
cytosol and at the mitochondria. It is possible that Parkin and
Ambra1 interact constitutively in the cytosol to cooperate in cy-
tosolic autophagic processes, such as the removal of misfolded
proteins. Indeed, genetic evidence has shown that continuous
clearance of cytosolic proteins through basal autophagy is essen-
tial to prevent neuronal accumulation of ubiquitinated proteins
and neurodegeneration (Hara et al., 2006; Komatsu et al., 2006).
The basal interaction of Parkin andAmbra1 in themitochondrial
fraction could reflect the fact that a minority of mitochondria
may become depolarized and dysfunctional even in basal, opti-
mal environmental conditions (Narendra et al., 2008).
The biochemical basis for the strongly increased binding of
Parkin and Ambra1 after mitochondrial depolarization remains
to be elucidated. Mitochondrial depolarization may lead to post-
translational modifications of Parkin or Ambra1 that enhance
their mutual affinity. Interestingly, Ambra1 was shown recently
to be phosphorylated byULK1 during induction of autophagy by
starvation (Di Bartolomeo et al., 2010a). It will be important to
determine whether Ambra1 phosphorylation similarly occurs
during mitochondrial depolarization and contributes to the in-
Figure 9. Ambra1 is recruited in a Parkin-dependent manner to perinuclear clusters of de-
polarizedmitochondria. A, At 24 h after transfection with Ambra1 alone (rows 1, 3) or cotrans-
fection with Ambra1 and Parkin (rows 2, 4, 5), HeLa cells were treated with DMSO or CCCP (10
M) for 16 h and immunostained for Parkin, Tom20, and Ambra1. The bottom row is a magni-
fication of the boxed area in the row above. B, Untransfected SH-SY5Y cells were treated with
DMSO or CCCP (25M) for 16 h and immunostained for cytochrome c and Ambra1. The bottom
row is a magnification of the boxed area in the row above. Scale bars, 10m.
Figure 10. Ambra1 locally activates class III PI3K around perinuclear clusters of depolarized
mitochondria. A, HeLa cells were cotransfected with Parkin, p40(phox)PX–EGFP, and the indi-
cated siRNA.At 24hafter transfection, cellswere treated for 16hwithCCCP (10M) and stained
for Parkin and Tom20. B, Quantification of the experiments illustrated in A. The number of
Parkin-positive cells with perinuclear mitochondrial clusters was quantified as a percentage of
the total number ofmitochondria-containing Parkin-positive cells (black bars; n 3). Also, the
number of Parkin-positive cells with perinuclear mitochondrial clusters in contact with
p40(phox)PX–EGFP hotspots was quantified as a percentage of the total number of
mitochondria-containing Parkin-positive cells (white bars; n 3). *p 0.001 comparedwith
control siRNA-treated cells. Scale bars, 10m.
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creased interaction with Parkin. An alternative mechanism for
the increased binding could be that depolarized mitochondria
recruit cofactors or binding partners of Parkin and Ambra1 that
facilitate their mutual interaction.
The remarkable ability of Ambra1 to translocate to the peri-
nuclear compartment during prolonged mitochondrial depolar-
ization may be related to its recently demonstrated dynamic
interaction with microtubule-associated dynein motors (Di Bar-
tolomeo et al., 2010a). Interestingly, Ambra1 also translocates to
the perinuclear region during induction of autophagy by starva-
tion (Di Bartolomeo et al., 2010a). After starvation-induced pe-
rinuclear redistribution, Ambra1 was found to be localized in
close proximity to omegasomes (Di Bartolomeo et al., 2010a).
Omegasomes are PtdIns-3-P-enriched structures in dynamic
equilibriumwith the endoplasmic reticulum (ER),which provide
a platform for accumulation of autophagy proteins and expan-
sion of autophagosomal membranes (Axe et al., 2008). Intrigu-
ingly, recent work has shown that the outer mitochondrial
membrane can also be a source of autophagosomal membranes
and that mitofusin 2-dependent connections between ER and
mitochondria are necessary for autophagosome formation dur-
ing starvation (Hailey et al., 2010). The source of the autophago-
somal membranes formed during mitophagy has not yet been
determined.
The core components of the class III PI3K complex are Vps34
(the actual kinase in the complex), Beclin1, and p150 (Funder-
burk et al., 2010; Yang and Klionsky, 2010). Ambra1 activates
class III PI3K by promoting the association of Beclin1with Vps34
(Fimia et al., 2007). Interestingly, Beclin1 was recently reported
to bind to PINK1 (Michiorri et al., 2010). Beclin1 only interacted
with full-length PINK1 and not with its cleaved isoforms (Michi-
orri et al., 2010). Importantly, PINK1 is constitutively cleaved
fromhealthy, polarizedmitochondria by voltage-dependent pro-
teolysis and only accumulates in its full-length form on depolar-
ized mitochondria (Matsuda et al., 2010; Narendra et al., 2010a).
Thus, the interaction of full-length PINK1 with Beclin1 could
provide an additional mechanism for local induction of au-
tophagy around depolarized mitochondria. Intriguingly, Beclin1
gene transfer ameliorated the neurodegenerative pathology in an
-synuclein transgenicmousemodel of PD (Spencer et al., 2009).
The class III PI3K complex and its regulators, including Ambra1,
could be attractive therapeutic targets for PD.
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